12 Health Care Stocks Moving In Monday's Intraday Session
Portfolio Pulse from Benzinga Insights
In Monday's intraday session, several healthcare stocks experienced significant movements. OneMedNet (ONMD) saw a 175.1% increase, while Palisade Bio (PALI) and NexImmune (NEXI) rose by 106.48% and 84.48%, respectively. FibroGen (FGEN), Atreca (BCEL), and Vivos Therapeutics (VVOS) also posted gains. Conversely, Panbela Therapeutics (PBLA), Processa Pharma (PCSA), Bullfrog AI Hldgs (BFRG), Inspire Veterinary (IVP), Corbus Pharmaceuticals (CRBP), and TC BioPharm (TCBP) experienced declines.
January 29, 2024 | 5:31 pm
News sentiment analysis
Sort by:
Ascending
NEGATIVE IMPACT
Bullfrog AI Hldgs stock fell 24.29% to $5.33, with a market value of $32.4 million.
Bullfrog AI Holdings' stock decline may suggest underlying issues or negative market sentiment, potentially leading to further short-term decreases.
CONFIDENCE 75
IMPORTANCE 75
RELEVANCE 100
NEGATIVE IMPACT
Corbus Pharmaceuticals shares fell 19.03% to $23.88, with a market value of $105.6 million.
The decline in Corbus Pharmaceuticals' stock price may reflect negative market reactions, potentially leading to further short-term downside.
CONFIDENCE 75
IMPORTANCE 75
RELEVANCE 100
NEGATIVE IMPACT
Inspire Veterinary stock declined by 23.31% to $0.17, with a market value of $1.8 million.
Inspire Veterinary's stock price drop could indicate negative news or investor sentiment, likely affecting the stock in the short term.
CONFIDENCE 70
IMPORTANCE 70
RELEVANCE 100
NEGATIVE IMPACT
Panbela Therapeutics shares fell by 67.2% to $1.4.
The sharp decline in Panbela Therapeutics' shares could reflect negative investor sentiment or adverse events, likely impacting the stock negatively in the short term.
CONFIDENCE 85
IMPORTANCE 90
RELEVANCE 100
NEGATIVE IMPACT
Processa Pharma stock dropped 29.98% to $2.57, with a market cap of $3.1 million.
Processa Pharma's significant stock price drop may continue to affect investor confidence negatively in the short term.
CONFIDENCE 80
IMPORTANCE 80
RELEVANCE 100
NEGATIVE IMPACT
TC BioPharm stock declined by 19.02% to $1.15.
TC BioPharm's stock decrease suggests potential negative sentiment or events, which could continue to impact the stock negatively in the short term.
CONFIDENCE 70
IMPORTANCE 70
RELEVANCE 100
POSITIVE IMPACT
Atreca shares increased by 42.09% to $0.35, with a market cap of $13.8 million.
Atreca's stock price movement suggests positive investor sentiment, which may persist in the short term.
CONFIDENCE 75
IMPORTANCE 70
RELEVANCE 100
POSITIVE IMPACT
FibroGen shares rose 54.93% to $1.45, with a market value of $142.5 million.
FibroGen's significant price increase could be indicative of positive developments, potentially leading to further short-term appreciation.
CONFIDENCE 80
IMPORTANCE 75
RELEVANCE 100
POSITIVE IMPACT
NexImmune shares increased by 84.48% to $9.87, with a market value of $10.4 million.
NexImmune's significant stock price rise could attract more attention, potentially leading to further short-term gains.
CONFIDENCE 85
IMPORTANCE 80
RELEVANCE 100
POSITIVE IMPACT
OneMedNet shares soared by 175.1% to $1.41, with a market cap of $45.3 million.
The substantial increase in OneMedNet's share price suggests a strong positive sentiment, likely to continue in the short term.
CONFIDENCE 85
IMPORTANCE 90
RELEVANCE 100
POSITIVE IMPACT
Palisade Bio shares jumped 106.48% to $1.07, with a market cap of $9.9 million.
The over 100% increase in PALI's stock price indicates strong investor interest, which may result in continued short-term upward momentum.
CONFIDENCE 85
IMPORTANCE 85
RELEVANCE 100
POSITIVE IMPACT
Vivos Therapeutics stock increased by 27.22% to $6.87, with a market value of $9.1 million.
The rise in Vivos Therapeutics' stock price could indicate a positive market reaction, potentially leading to more short-term gains.
CONFIDENCE 75
IMPORTANCE 65
RELEVANCE 100